Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A PHASE 3 CLINICAL PROGRAM OF THREE, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND COIMPARATOR-CONTROLLED STUDIES TO ASSESS THE EFFICACY AND SAFETY OF OTILIMAB IN RA: STUDY DESIGN AND METHODOLOGY Genovese, M., Taylor, P. C., Boers, M., Strand, V., Saurigny, D., Davy, K., Gupta, A., Harrison, S., Hepburn, R., Patel, J., Layton, M., Wang, M., Fleischmann, R. LIPPINCOTT WILLIAMS & WILKINS. 2020: 20
View details for Web of Science ID 000530661500057